Consider an illustrative case: a 36-year-old feels a flutter in her chest and light-headedness, turns pale, and falls limply. A witness sees a few irregular arm jerks after she reaches the floor; within a minute, she is speaking coherently. The high-stakes question is not simply whether the episode looked dramatic. It is whether this was an epileptic seizure at all—and, only if it was, whether starting an antiseizure medication now is justified.
The distinction matters. A prescription cannot treat an unrecognized cardiac cause, and an epilepsy label may affect safety advice, work, driving, and future care. Yet deferring treatment is not automatically right if the event was a true seizure with a high risk of recurrence.
Keep three decisions separate
First, classify the event. In this case, the presyncopal sensation, pallor, limp fall before the movements, and quick return to coherent speech make syncope with brief motor activity plausible. They do not prove it. A handful of jerks, by itself, does not establish an epileptic seizure; neither does the absence of tongue injury or incontinence rule one out.
Second, ask whether an epileptic event—if that is the best formulation—meets criteria for epilepsy. The ILAE practical definition recognizes epilepsy through any of three routes: at least two unprovoked (or reflex) seizures more than 24 hours apart; one unprovoked (or reflex) seizure with an estimated recurrence probability of at least 60% over the next 10 years; or diagnosis of an epilepsy syndrome.
Third, decide whether to treat. Diagnosis and treatment are related but not interchangeable: a confirmed epilepsy diagnosis generally prompts antiseizure treatment, but treatment may also be considered after one seizure before epilepsy criteria are met. In either situation, the plan should account for recurrence risk, likely benefits and harms, and the person’s preferences.
Check that “first seizure” is actually the right starting point
Before applying recurrence estimates, establish whether the event was likely epileptic and whether it was unprovoked. Get the patient’s account and witness description, including what happened before the fall, when movements began, and how awareness returned. Ask directly about earlier stereotyped spells that may not have been recognized as seizures, including brief lapses in awareness, unusual sensory experiences, nocturnal events, or morning jerks. Clarify neurologic baseline, prior brain injury or disease, medications, and relevant substance use. A history of no previous medical assessment is not, by itself, proof that no earlier events occurred.
For adults with a confirmed first unprovoked seizure, recurrence is most likely in the first two years; one guideline estimates a 21–45% risk in that period. Risk is higher with factors such as a prior brain insult, epileptiform activity on EEG, a significant brain-imaging abnormality, or a seizure during sleep. These figures do not apply to every collapse with jerking. They also should not be converted into a simple score by adding risk factors together.
In this case, EEG and brain imaging results have not been provided. Do not quietly treat missing results as normal—or order tests simply to make an uncertain collapse fit a seizure framework. An EEG is not a screening test for every unexplained blackout. If the history supports seizure, EEG can support the diagnosis and help characterize seizure type; a normal routine EEG does not exclude epilepsy. Brain imaging is relevant when a structural cause is suspected.
Match treatment to the person’s risk and priorities
After a genuine first unprovoked seizure, immediate medication can reduce the chance of another seizure over the next two years. It is unlikely to improve the longer-term chance of sustained seizure remission, and treatment has potential adverse effects. The decision therefore turns on the person’s estimated recurrence risk, the consequences another event could have, treatment burdens, and the patient’s preferences—not on a rule that everyone must start medication after one event or must wait for a second.
Earlier treatment may be reasonable when there is a neurologic deficit, unequivocal epileptic activity on EEG, a structural brain abnormality, or when an informed patient considers the risk of another seizure unacceptable. These are reasons for an individualized discussion, not a substitute for first deciding whether the episode was epileptic. If medication is being considered, the seizure type and the person’s other health and reproductive considerations matter when choosing a drug.
For this patient, the available description does not establish a first unprovoked seizure. It therefore does not, on its own, justify starting long-term antiseizure treatment. The palpitations and light-headedness before collapse keep a cardiac mechanism in play; a normal single ECG records one moment and does not exclude an intermittent rhythm problem. Neurologic assessment should not replace appropriate evaluation of the unexplained loss of consciousness.
Traps that turn uncertainty into a prescription
- Equating jerks with epilepsy: Movements must be interpreted in the sequence of the whole event.
- Applying first-seizure recurrence statistics to any blackout: Those estimates assume the event was an unprovoked epileptic seizure.
- Treating the diagnostic threshold as a medication threshold: A diagnosis informs treatment, but the plan must still consider the individual’s risk, likely benefits and harms, and preferences.
- Using an EEG as a verdict: It may support a diagnosis, but a normal routine result cannot rule epilepsy out, and the event history remains central.
- Letting a possible seizure close the cardiac work-up: The neurological and cardiovascular questions can remain open at the same time.
Practical takeaways
- Establish that an event was likely epileptic before applying first-seizure treatment guidance.
- Separate event classification, epilepsy diagnosis, and the decision to start medication.
- Use EEG, imaging, history, and examination to inform recurrence risk; do not treat missing findings as negative.
- Discuss early treatment when recurrence risk or its consequences matter, while making the choice with the patient.
- Keep the evaluation directed at syncope active when the history supports a possible cardiac cause.
